Results 61 to 70 of about 74,348 (167)

Juvenile Xanthogranuloma With Hydrocephalus

open access: yesIndian Journal of Dermatology, 2004
Juvenile xanthogranuloma (JXG) is a rare, benign, self-healing tumor of unknown etiology arising from non-Langerhans’ cell histiocytes.
Ghosh Arghyaprasun   +4 more
doaj  

Necrobiotic xanthogranuloma: A case report of successful treatment with intravenous immunoglobulins

open access: yesJEADV Clinical Practice, Volume 3, Issue 4, Page 1248-1252, September 2024.
Abstract Necrobiotic xanthogranuloma (NXG) is a rare non‐Langerhans cell histiocytosis associated with paraproteinemia. Skin lesions of NXG are difficult to treat and various therapies have been evaluated with inconsistent results. A therapeutic standard has not been established.
Julia K. Winkler   +4 more
wiley   +1 more source

An Atypical Presentation of a Rare Disease [PDF]

open access: yes, 2019
A 76-year-old white woman presented for evaluation of asymptomatic skin lesions on her right shin, right buttock, and left arm. All lesions initially underwent slow growth and plateaued and then remained stable in size.
Connolly, Deirdre   +3 more
core   +1 more source

A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case Report [PDF]

open access: yes, 2011
Necrobiotic xanthogranuloma (NXG) is a rare destructive xanthomatous granuloma with chronic, indolent, and progressive course. The morbidity and mortality are the results from wound complications and associated disorders.
Inthasotti, Siriluk   +2 more
core   +4 more sources

Pilomatricoma in the infraorbital region

open access: yesClinical Case Reports, Volume 12, Issue 8, August 2024.
Key Clinical Message Pilomatricoma, a rare benign skin tumor arising from hair follicle matrix cells, warrants consideration in the evaluation of subcutaneous nodules or masses, especially when presenting as painless and firm lesions. Accurate diagnosis hinges on histopathological examination, underscoring the significance of clinician vigilance and ...
Dilasha Dhungel   +3 more
wiley   +1 more source

Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation [PDF]

open access: yes, 2018
Paraproteinemia can be complicated by necrobiotic xanthogranuloma. Therapeutic options for this progressive disease are limited, and there is no agreement on a single best strategy.
Dispenzieri, Angela   +7 more
core  

Cutaneous crystal storing histiocytosis: A case series with review of literature

open access: yesJournal of Cutaneous Pathology, Volume 51, Issue 7, Page 506-512, July 2024.
Abstract Crystal‐storing histiocytosis (CSH) is a rare condition in which crystals accumulate in the cytoplasm of histiocytes and is usually associated with a lymphoplasmacytic neoplasm. Cutaneous CSH is extraordinarily rare and limited to case reports in the literature. We report two cases of this disease with cutaneous involvement.
Haya A. Homsi   +6 more
wiley   +1 more source

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue [PDF]

open access: yes
Juvenile xanthogranuloma (JXG) is a histiocytic neoplasm that usually presents in the skin. Rarely, extracutaneous localizations occur; the genetic drivers of this clinical variant of JXG remain incompletely characterized.
Al-Hussaini, Maysa   +25 more
core   +1 more source

Erdheim-Chester Disease: a comprehensive review of the literature [PDF]

open access: yes, 2013
Erdheim-Chester Disease (ECD) is a rare form of non Langerhans' cell histiocytosis. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. Males and females are almost equally affected.
Mirra Manevich-Mazor   +2 more
core   +1 more source

Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil. [PDF]

open access: yes, 2001
Eur J Dermatol. 2001 Sep-Oct;11(5):458-62. Cutaneous necrobiotic xanthogranuloma (NXG)--successfully treated with low dose chlorambucil. Machado S, Alves R, Lima M, Leal I, Massa A.
Alves, R.   +4 more
core  

Home - About - Disclaimer - Privacy